Bridging study to launch after coming Oct.

Published: 1999-09-14 13:53:00

Updated: 1999-09-14 13:53:00

The revised bill of "Regulation pertaining to Drug Safety and Efficacy Evaluation" looks delayed in its implementation probably after the coming Oct. The regulation replaces the current clinical phase III study requirement for a new drug registration by so-called bridging study in an attempt to r...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK